Clinical Trial Update: SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 trial update for SGN-00101 immunotherapy in patients with cervical intraepithelial neoplasia grade III (a precancerous cervical condition) and related c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia Grade Iii

Drugs mentioned

• SGN-00101

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Cervical Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED